Legal Representation
Attorney
Kevan L. Morgan
USPTO Deadlines
Next Deadline
541 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-05)
Due Date
January 05, 2027
Grace Period Ends
July 05, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 5, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Dec 3, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Dec 2, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Oct 29, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Oct 29, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Oct 13, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Oct 13, 2020 | IUAF | S | USE AMENDMENT FILED |
May 26, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 31, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 31, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 11, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Feb 25, 2020 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Feb 21, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Feb 20, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 20, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Feb 19, 2020 | ALIE | A | ASSIGNED TO LIE |
Feb 13, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Jul 31, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN |
Jul 31, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
Jul 31, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Jul 9, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
May 30, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
May 29, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
May 29, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
May 9, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
May 9, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
May 9, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
May 9, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
May 6, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 23, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Diagnostic preparations for research; Diagnostic agents and diagnostic substances for scientific purposes, in particular immobilised proteins, nucleic acids, allergens and biological tissue sections being cultures on a carrier or a carrier material, in the nature of a microsphere, paper ring, test strip, blot, microtiter plate or membrane
First Use Anywhere:
Jan 16, 2019
First Use in Commerce:
Jan 16, 2019
Class 005
Diagnostic agents, in particular diagnostic agents for medical and veterinary purposes for detection of allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposes, in particular immobilised proteins, nucleic acids, allergens and biological tissue sections being cultures on a carrier or carrier material, in the nature of a microsphere, test strip, blot, microtiter plate or membrane; Reagents for medical and veterinary diagnostic purposes, namely, veterinary diagnostic reagents and medical diagnostic reagents; Reagents for medical and veterinary diagnosis being veterinary diagnostic reagents and medical diagnostic reagents, in particular immobilised proteins, nucleic acids, allergens and biological tissue sections being cultures on a carrier or a carrier material, in the nature of a microsphere, paper ring, test strip, blot, microtiter plate or membrane
First Use Anywhere:
Jan 16, 2019
First Use in Commerce:
Jan 16, 2019
Classification
International Classes
001
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO